Skip to main content
Fig. 3 | Cancer Communications

Fig. 3

From: Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Fig. 3

Percentage change in functional parameters of D-CEUS on day 8 and 15 from baseline. a PI peak intensity, b AUC area under the curve, c PW slope of wash-in, d WIPI wash-in perfusion index. Data truncated at 100%. Horizontal line at − 30% marks threshold for functional parameters response

Back to article page